Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $39.98 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• RBC Capital Starts Northview Residential REIT (NRR-U:CN) at Sector Perform